Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Medicago to get 173m in funding from Canada Gov
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2)
•••
Comment by bikkel78on Oct 26, 2020 12:48pm
215 Views
Post# 31781916

RE:RE:RE:RE:RE:RE:RE:Medicago to get 173m in funding from Canada Gov

RE:RE:RE:RE:RE:RE:RE:Medicago to get 173m in funding from Canada Gov

For Medicago it is great news. They really needed that money as they have a $450M facility under construction and no product approved yet.

I hope they will have a full set of data that will include the toxicity and challenge studies very soon. They will need it to start the phase 1/2. I see this as the key value driver.

Also, the data on DLBCL is good already. Time for Merck to bite the bait. What are the chances IMV will partner with Merck?

 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities